Vol. 2 No. 2 (2014): October 2014

Published: 2014-10-31

Editorial

Weekly paclitaxel with carboplatin in the first line treatment of advanced ovarian cancer

Nicoletta Colombo

3-4
- PDF

Review

Role of trabectedin in BRCA-mutated patients

D. Lorusso, C. Kahatt, P. Lardelli

5-10
- PDF

Interview

Single-agent chemotherapy versus polychemotherapy in first-line treatment of advanced soft tissue sarcoma: for and against on the basis of the recent EORTC 62012 phase III trial

B. Kasper, G. Grignani, G.G. Baldi

11-14
- PDF

Breaking from the Lab

Genetic profiling in ovarian cancer

C. Marchetti, J.A. Rauh-Hain, P. Benedetti Panici, M. Birrer

15-22
- PDF

Clinical original article

Brain metastases from early stage endometrial carcinoma: a challenging issue

A. Bergamini, E. Rabaiotti, P. De Marzi, D. Ferrari, M. Petrone, R. Viganò, G. Mangili

23-25
- PDF
Trabectedin in synovial sarcoma: a retrospective case series analysis from two reference centers

A. Marrari, R. De Sanctis, G.G. Baldi, A. Di Leo, V. Quagliuolo, A. Santoro

26-30
- PDF

Meet the expert

Case 1 – Disseminated abdominopelvic actinomycosis mimicking infiltrating peritoneal carcinomatosis: a misdiagnosis of advanced ovarian malignancy

C. Scaffa, N.S. Losito, Francesco Raspagliesi

31-34
- PDF
Case 2 – Multiple cytoreductive surgeries for metastatic advanced ovarian cancer: a case report

C. Marchetti, A. Musella, C. Sassu, A. Giannini, C. Pisano, Sandro Pignata

35-38
- PDF

Methodological corner

Directness and quality of evidence of bevacizumab combined with chemotherapy for platinum-resistant, recurrent ovarian cancer in the AURELIA trial

G.L. Pappagallo, M. Rizzo

39-41
- PDF

Letter to the Editor

Letter to the Editor

Anna Fagotti

42-43
- PDF